The tumult of large-scale cuts to federal spending, pullbacks of civil rights protections, and new tariffs getting announced ...
Dolutegravir plus lamivudine shows comparable efficacy and safety with standard-of-care three-drug regimen in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback